Oocyte Vitrification Using the HSV Kits : An Abstract

By: Cryo Bio Sysytem
 
CHICHESTER, U.K. - Nov. 18, 2024 - PRLog -- CRYOLAB LIMITED Porcu et al, 2021 : High-security closed devices are efficient and safe to protect human oocytes from potential risk of viral contamination during vitrification and storage especially in the COVID-19 pandemic Abstract : The main purpose and research question of the study are to compare the efficacy of high-security closed versus open devices for human oocytes' vitrification. Methods: A prospective randomized study was conducted. A total of 737 patients attending the Infertility and IVF Unit at S.Orsola University Hospital (Italy) between October 2015 and April 2020 were randomly assigned to two groups. A total of 368 patients were assigned to group 1 (High-Security Vitrification™ – HSV) and 369 to group 2 (Cryotop® open system). Oocyte survival, fertilization, cleavage, pregnancy, implantation, and miscarriage rate were compared between the two groups. Results: No statistically significant differences were observed on survival rate (70.3% vs. 73.3%), fertilization rate (70.8% vs. 74.9%), cleavage rate (90.6% vs. 90.3%), pregnancy/transfer ratio (32.0% vs. 31.8%), implantation rate (19.7% vs. 19.9%), nor miscarriage rates (22.1% vs. 21.5%) between the two groups. Women's mean age in group 1 (36.18 ± 3.92) and group 2 (35.88 ± 3.88) was not significantly different (P = .297). A total of 4029 oocytes were vitrified (1980 and 2049 in groups 1 and 2 respectively). A total of 2564 were warmed (1469 and 1095 in groups 1 and 2 respectively). A total of 1386 morphologically eligible oocytes were inseminated by intracytoplasmic sperm injection (792 and 594 respectively, P = .304). Conclusions: The present study shows that the replacement of the open vitrification system by a closed one has no impact on in vitro and in vivo survival, development, pregnancy and implantation rate. Furthermore, to ensure safety, especially during the current COVID-19 pandemic, the use of the closed device eliminates the potential samples' contamination during vitrification and storage.

READ THE FULL ARTICLE HERE - Oocyte Vitrification Using the HSV Kits : An Abstract - Cryolab (https://cryolab.co.uk/oocyte-vitrification-using-the-hsv-...)

For product information, email us at info@cryolab.co.uk or visit our website Cryolab - Specialist in Cryogenic laboratory products for IVF (https://cryolab.co.uk/)
Source : CryoBioSystem

Contact
Rushi
info@cryolab.co.uk
01243837177
End
Source:Cryo Bio Sysytem
Email:***@cryolab.co.uk Email Verified
Tags:Ivf
Industry:Medical
Location:Chichester - West Sussex - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cryolab Ltd News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share